Delivery Order SPE2DB20D3103-SPE2DB24FL6Y2
Award Date 11/28/23
Potential Completion Date 11/29/23
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,431.06 firm fixed-price delivery order is for the supply of HEMABATE 250MCG/ML 10S, a pharmaceutical product, with a completion date of November 5, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $81,531.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a completion date of February 8, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was made by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,393.64 firm fixed-price delivery order is for 250 MCG/ML Hemabate ampules, a medication used to control postpartum bleeding. The contract has an ultimate completion date of August 20, 2024 and does not utilize any set-aside designation. As one of the largest pharmaceutical distributors in the U.S.,...
- The Defense Logistics Agency awarded a $2,119.75 delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/mL ampules, with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HEMABATE 250 MCG/ML ampules, with a ceiling value of $4,239.50 under a firm fixed-price contract structure. This non-set-aside award was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. HEMABATE (carboprost tromethamine) is a pharmaceutical product used in obstetric and gynecological applications. The performance location is AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency issued a $1,402.56 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Hemabate 250 mcg/ml ampules, with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,224.98 and covers the delivery of 2,400 units of HUMATE-P, a medication used to treat von Willebrand disease. The contract is a firm fixed-price delivery order with a completion date of March 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,418.50 Firm Fixed Price Delivery Order contract has a ceiling value of $2,418.50 and an ultimate completion date of December 11, 2024. This award is not associated with a set-aside program. The contract covers the delivery of a range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,032.40 firm fixed-price delivery order is for AMPHADASE 150 UNITS/ML VIAL, a medical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $23,074.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...